Search Results for "dose strategy" | Oncology Voice Network

Leon Rozen

Medical Judgment at the Point of Decision

Feb 12^th • 5 mins read

Michael Pietrack

Leadership Lab: Take a Cue From Athletes by Working With an Executive Coach

Feb 19^th • 6 mins read

Michael Pietrack

Leadership Lab: 5 Steps for Building Your Personal Brand

Aug 19^th • 5 mins read

Michael Pietrack

Leadership Lab: 4 Ways Biopharma Leaders Can Prepare for Media Interviews

Aug 20^th • 6 mins read

Michael Pietrack

Managing Emotions After Being Downsized

Oct 21^st • 5 mins read

Michael Pietrack

Resume Advice: Tattoos and Breadcrumbs

Jul 14^th • 5 mins read

Michael Pietrack

The Great Resignation is Now The Great Hesitation

Nov 19^th • 5 mins read

Forbes Books Press Release Official

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Sep 9^th • 5 mins read

Tom Caravela

Job Search Checklist for Aspiring Medical Science Liaisons

May 17^th • 2 mins read

Tom Caravela

MSL Retention – What Matters Most

Mar 15^th • 2 mins read

Tom Caravela

MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion

May 19^th • 2 mins read

Tom Caravela

7 High-Cost Interview Mistakes that are Easy to Avoid

Jul 28^th • 1 min read

Tom Caravela

INTENTION: The Key to Achieving Your Goals

Jan 21^st • 1 min read

Tom Caravela

MSL People Skills: Top 10 Tips for Better Engagement

Apr 20^th • 8 mins read

iNIZIO

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Sep 3^rd • 1 min read

iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

May 16^th • 5 mins read

iNIZIO

Expert perspectives live from ASCO® 2025

Jul 2^nd • 1 min read

Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Feb 23^rd • 8 mins read

Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Sep 27^th • 1 min read

Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Nov 20^th • 12 mins read

Navigation

Results for 'dose strategy'

Medical Judgment at the Point of Decision

Leadership Lab: Take a Cue From Athletes by Working With an Executive Coach

Leadership Lab: 5 Steps for Building Your Personal Brand

Leadership Lab: 4 Ways Biopharma Leaders Can Prepare for Media Interviews

Managing Emotions After Being Downsized

Resume Advice: Tattoos and Breadcrumbs

The Great Resignation is Now The Great Hesitation

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Job Search Checklist for Aspiring Medical Science Liaisons

MSL Retention – What Matters Most

MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion

7 High-Cost Interview Mistakes that are Easy to Avoid

INTENTION: The Key to Achieving Your Goals

MSL People Skills: Top 10 Tips for Better Engagement

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Transforming oncology: Five frontiers driving progress in cancer care

Expert perspectives live from ASCO® 2025

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Related Topics